This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MODV vs. PGNY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MODV vs. PGNY: Which Stock Is the Better Value Option?
Best Momentum Stocks to Buy for August 10th
by Zacks Equity Research
TTMI, CIGI and MODV made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 10, 2022.
Does ModivCare (MODV) Have the Potential to Rally 32% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for ModivCare (MODV) points to a 31.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ModivCare (MODV) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ModivCare (MODV) delivered earnings and revenue surprises of 39.16% and 7.99%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Doximity (DOCS) Surges 6.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Doximity (DOCS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ModivCare (MODV) Q1 Earnings Lag Estimates
by Zacks Equity Research
ModivCare (MODV) delivered earnings and revenue surprises of -0.63% and 1.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: ModivCare (MODV) Q1 Earnings Expected to Decline
by Zacks Equity Research
ModivCare (MODV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 34.13% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ModivCare (MODV) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
ModivCare (MODV) delivered earnings and revenue surprises of 28.66% and 4.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
CareDx (CDNA) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareDx (CDNA) delivered earnings and revenue surprises of -250% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
ModivCare (MODV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
ModivCare (MODV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) Q4 Earnings Beat Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 5.60% and 0.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: TimkenSteel, ModivCare, Capital Product Partners, Euroseas and DLH Holdings
by Zacks Equity Research
TimkenSteel, ModivCare, Capital Product Partners, Euroseas and DLH Holdings are highlighted in this screen of this week article.
Walgreens Boots (WBA) Q1 Earnings Top Estimates, 2022 View Up
by Zacks Equity Research
Walgreens Boots' (WBA) revenues increased year over year in the fiscal first quarter, driven by COVID-19 vaccinations and testing.
Solid Net Profit Margin Makes These 5 Stocks Worth Buying Now
by Anirudha Bhagat
Let's take a look at these five top-ranked stocks, TMST, MODV, CPLP, ESEA and DLHC, with impressive net profit margins for a winning portfolio.
MODV vs. AMEH: Which Stock Is the Better Value Option?
by Zacks Equity Research
MODV vs. AMEH: Which Stock Is the Better Value Option?
ModivCare (MODV) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
Walgreens (WBA) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Faster adoption of digital health and recent partnerships are expected to have contributed to Walgreens' (WBA) first-quarter performance.
Zacks.com featured highlights include: Fidelity National Financial, ModivCare, Deutsche Post and TimkenSteel
by Zacks Equity Research
Zacks.com featured highlights include: Fidelity National Financial, ModivCare, Deutsche Post and TimkenSteel.
4 Stocks Riding High on Increasing Cash Flow to Buy Now
by Moumita C. Chattopadhyay
Analyzing a company's cash position can be rewarding because it reveals its true financial health. In this regard, stocks like Fidelity National Financial (FNF), ModivCare (MODV), Deutsche Post AG (DPSGY) and TimkenSteel (TMST) are worth buying.
Zacks.com featured highlights include: TimkenSteel, One Stop Systems, Fidelity National Title Group, Citi Trends and ModivCare
by Zacks Equity Research
Zacks.com featured highlights include: TimkenSteel, One Stop Systems, Fidelity National Title Group, Citi Trends and ModivCare
5 Stocks With Solid Net Profit Margin to Enrich Your Portfolio
by Anirudha Bhagat
Let's take a look at the five top-ranked stocks - TMST, OSS, FNF, CTRN and MODV - with stellar net profit margins for a winning portfolio.
MODV vs. GDRX: Which Stock Is the Better Value Option?
by Zacks Equity Research
MODV vs. GDRX: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: TimkenSteel, Deutsche Post, PDC Energy and ModivCare
by Zacks Equity Research
Zacks.com featured highlights include: TimkenSteel, Deutsche Post, PDC Energy and ModivCare
Scoop Up Big Gains With 4 Stocks Enjoying Rising Cash Flows
by Moumita C. Chattopadhyay
Cash is the most indispensable factor for any company. It provides strength and vitality to a company, as well as holds the key to its existence, development and success.